CD14 and chronic kidney disease: Similarly, the number and percentage of the non-classical CD14+CD16++ monocytes were lower in KTRs [18 (IQR 13–28)/μL and 3.2 (IQR, 1.9–5.4)%] compared to their CKD counterparts [25 (IQR, 19–36)/μL and 5.8 (IQR, 4.3–8.2)%, p = 0.001 and 0.000, respectively].